Some Healthcare Providers Remain Skeptical of Biosimilars

Biosimilars generic2

An APCO Insight survey conducted in 2015 has revealed that a significant percentage of healthcare providers and opinion leaders still remain skeptical of biosimilars. The survey found that 36 percent of healthcare providers and 29 percent of opinion leaders answered “in between” when asked how similar or different a biosimilar is to its reference biologic. The study revealed skepticism that could prevent biosimiliars from being quickly adopted in the United States.

Read the source article at PharmaPro

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>